Zurletrectinib was developed to treat advanced or metastatic solid tumors harboring NTRK fusion genes
Ensitrelvir is an oral antiviral that suppresses the replication of SARS-CoV-2 by selectively inhibiting the viral 3CL protease.
Dignitaries and delegates commend India’s leadership in Global South during G20 India Presidency
Granules now has a total of 58 ANDA approvals from US FDA
Lebrikizumab is an investigational high-affinity and potent IL-13 inhibitor being studied in adult and adolescent patients
Licences should enable potentially millions of people living in areas most impacted by HIV to access this innovative prevention medicine through low-cost generic manufacturers
The Indian government will float a global tender in April 2023 to procure HPV vaccines.
Label expansion for CIBINQO provides new systemic oral option for adolescents (12 to <18 years) with moderate-to-severe atopic dermatitis
The agreement between Eli Lilly and Janssen was established to allow the two companies to share resources for the goal of accelerating the evaluation of the respective companies’ assets, mirikizumab and Tremfya (guselkumab).
For anaemia control in children (0-19 years) & resolves for Call to Action in this direction
Subscribe To Our Newsletter & Stay Updated
